Parvovirus B19 DNA, Qualitative Real-Time PCR [34296X]

Test Code
5319


CPT Codes
87798

Preferred Specimen
1 mL plasma collected in EDTA (lavender-top), ACD (yellow-top) or PPT potassium EDTA (white-top) tube or
1 mL whole blood collected in EDTA (lavender-top) or ACD (yellow-top) tube or
1 mL amniotic fluid or amniotic fluid supernatant collected in a sterile, leak-proof container or
1 mL serum or
> 3 cubic mm tissue collected in a sterile, plastic leak-proof container


Minimum Volume
>3 cubic mm fresh tissue
0.3 mL all other specimens


Transport Temperature
Whole blood: Refrigerated (cold packs)
All other samples: Frozen


Specimen Stability
Whole blood
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: Unacceptable

All other specimens
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 30 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolyzed whole blood • Heparin plasma or whole blood


Methodology
Real-Time Polymerase Chain Reaction (PCR)

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule
Set up: Daily; Report available: 1-2 days


Reference Range
Not detected


Clinical Significance
Parvovirus B19 is the cause of an infection known as "Fifth Disease". This infection affects children primarily and causes a rash on the face, trunk, and limbs. Joint pain and swelling is more common in adults. Although a portion of those affected have only mild disease, patients with sickle cell anemia, or similar types of chronic anemia, can suffer from severe acute anemia. Infection during pregnancy can lead to severe complications for the fetus. Infections in immunocompromised patients may lead to serious complications including nephropathy, myocarditis, and persistent anemia. Although serologic detection of circulating antibodies (Parvovirus B-19 IgM & IgG) is useful to determine recent exposure to the virus, DNA testing provides the most reliable evidence of a persistent infection. Quantitative results of Parvovirus B19 viral load may be useful in determining the response to therapy (usually IVIG) and may be beneficial in assessing the risk for nosocomial transmission.


Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.